AKT1 and thyroid gland carcinoma: PI3K/Akt/mTOR is often activated in malignancies, and the Ras/Raf/MEK/ERK signaling pathway is enhanced in pancreatic cancer [102], colon cancer [103], and thyroid cancer [104].